Search form
Search
Login
Subscribe
Home
Country Intelligence
Industry Directory
Offsets / IC
Tenders
Haiti
(0/week)
Guyana
(0/week)
Honduras
(0/week)
Jamaica
(0/week)
Netherlands Antilles
(0/week)
View all
(0/week)
News
United States
(1329/week)
Manufacturing
(694/week)
Energy
(566/week)
Technology
(1266/week)
Other Manufacturing
(486/week)
Events
About us
Who we are
Our People
Partners
Contact us
LinkedIn
Login
Twitter
Register
Home
News
Viracor-IBT Laboratories
Viracor-IBT Laboratories
May 28, 2020
Arranta Bio Announces Completion of its Microbiome Process Development Laboratory Expansion and Commitment to Additional Early Clinical GMP Capacity
Apr 15, 2020
Eurofins - Transplant Genomics Announces TRULO Registry Study to Evaluate Long-Term Clinical Outcomes in Patients Monitored with TruGraf® Testing
Mar 30, 2020
Viracor Eurofins Launches Labs@HOME, a Mobile Phlebotomy Service for Post-Transplant Patient Testing
Mar 04, 2020
Nexelis to Acquire Specialty Immunogenicity and Immune-Oncology Testing Laboratory ImmunXperts
Jan 10, 2020
Transplant Genomics, Inc. Appoints Dr. John Holman as VP Medical Affairs
Dec 11, 2019
Viracor Eurofins Expands Its Clinical Diagnostic Footprint to Oncology
Dec 05, 2019
MolDX sets TruGraf® reimbursement level
Dec 04, 2019
Canopy Biosciences Acquires Core Diagnostics
Aug 21, 2019
Viracor Eurofins Collaborates with Northwestern University Comprehensive Transplant Center on Specialized Kidney Transplant Diagnostic
May 30, 2019
Ampersand Capital Partners to Acquire Vibalogics GmbH
May 08, 2019
Ampersand Capital Partners completes Growth Equity Investment in Transplantation Diagnostic firm GenDx
Dec 11, 2018
Histo-Scientific Research Laboratories and Vet Path Services Merge
Nov 19, 2018
Ampersand Capital Partners Acquires Pacific Biomarkers and Merges Company with NEOMED-LABS
Sep 04, 2018
Ampersand Invests in Management Buyout of Clinical Immunology Provider NEOMED-LABS from the NEOMED Institute
Aug 21, 2018
Viracor Eurofins Announces Medical Advisory Board
Mar 26, 2018
MedPharm Receives Growth Equity Investment from Ampersand Capital Partners
Mar 20, 2018
Nexcelom Bioscience announces strategic growth investment from Ampersand Capital Partners
Latest News
Aug 2, 2025
SSP Innovations and 3-GIS Set Stage for Strategic Realignment
Aug 2, 2025
Helix to Participate in Upcoming Events
Aug 2, 2025
Maryland American Water Files Rate Request Driven by $22 Million of Investment Over Last Seven Years
Aug 2, 2025
Playback Now Available for AM Best-Hosted Webinar on Navigating Construction Risk
Aug 2, 2025
Europe Pyridine Market Forecast and Company Analysis Report 2025-2033 Featuring Lonza, Bayer, Jubilant...
Aug 2, 2025
BioConsortia Closes Financing to Accelerate Launch of Next-Generation Nitrogen-Fixing Biofertilizer and Fuel...
Aug 2, 2025
Simms and the Grateful Dead Announce Dead on the Water
Aug 2, 2025
Anaergia S.r.l. to Expand and Upgrade Moglia Anaerobic Digestion Facility for Bioenerys in Italy
View all News
Agenda
30
September
Portugal
Troia, Portugal
Seabed Security, 30 September - 01 October 2025, Troia, Portugal
Seabed Security | 30 September - 01 October 2025 | Troia, Portugal Defence iQ Announces Inaugural Seabed Security...
23
September
United Kingdom
London, UK
Countering Explosive Threat & Demining conference, September 23 - 24, 2025, London, UK
Countering Explosive Threat & Demining conference | September 23 - 24, 2025 | London, UK The Countering Explosive...
View All Events